Skip to main content

Advertisement

SpringerLink
Log in

Recurrence of meningiomas versus proliferating cell nuclear antigen (PCNA) positivity and AgNOR counting

  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

Meningiomas have a wide range of biological potential and clinical behaviour. Histological findings are helpful in recognizing the malignant potential but often fail to correlate with clinical behaviour. This study attempts to correlate the silver nucleolar organizer regions (AgNORs) and proliferating cell nuclear antigen (PCNA) with clinicopathological features of biological activity. Thirty-four completely resected meningiomas were classified as benign [19], atypical [6] and malignant [9]. Forty-eight initial and recurrent tumour materials were investigated for staining of AgNORs and immunohistochemistry using monoclonal antibodies against PCNA (clone 19A2 and PC10). There were no differences between the recurrent and non-recurrent cases with regards to AgNOR, PC10 and 19A2 values. Also, no significant difference was found between the primary and recurrent tumours. Both PC10 and 19A2 labelling indices (LI) showed a significant difference between benign and malignant meningiomas. The 19A2 LI was 0.56 ± 0.21 in benign and 2.45 ± 16 in atypical meningiomas. The 19 A2 counts showed significant difference between benign and atypical tumours but PC10 values failed to show such a correlation. AgNOR and PCNA indices were not found to be useful in predicting recurrences compared to the surgical procedure and histopathological criteria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adegbite AB, Khan MI, Paine KWE, Tan LK (1983) The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58: 51–56

    PubMed  Google Scholar 

  2. Allegranza A, Girlando S, Arrigoni GL,et al (1991) Proliferating cell nuclear antigen expression in central nervous system neoplasm. Virchow Archiv A Pathol Anat 419: 417–423

    Google Scholar 

  3. Boon AP, Sharif H (1989) Value of AgNOR method in predicting recurrence of meningioma. J Clin Pathol 42: 1002–1003

    Google Scholar 

  4. Borovich B, Doron Y (1986) Recurrence of intracranial meningiomas: the role played by regional multicentricity. J Neurosurg 64: 58–63

    PubMed  Google Scholar 

  5. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H (1987) Cyclin/PCNA is the auxiliary protein of DNA polymerase delta. Nature 326: 515–517

    PubMed  Google Scholar 

  6. Burger PC, Scheithauer BW, Vogel FS (1991) Surgical pathology of the nervous system and its coverings, 3rd Ed. Churchill Livingstone, New York, pp 67–92

    Google Scholar 

  7. Chin SL, Hinton DR (1991) The standardized assessment of argyrophilic nucleolar organizer regions in meningeal tumors. J Neurosurg 74: 590–596

    PubMed  Google Scholar 

  8. Cracker J, Boldy DAR, Eagen MJ (1989) How should we count AgNORs? Proposal for a standard approach. J Pathol 158: 185–188

    PubMed  Google Scholar 

  9. Crone KR, Challa VR, Kute TE, Moody DM, Kelly DL (1988) Relationship between flow cytometric features and clinical behavior of meningiomas. Neurosurg 23: 720–724

    PubMed  Google Scholar 

  10. Garcia RL, Coltrera MD, Gown AM (1989) Analysis of proliferative grade using anti PCNA-cyclin monoclonal antibodies in fixed, embedded tissues. Compression with flow cytometric analysis. Am J Pathol 134: 733–739

    PubMed  Google Scholar 

  11. Gelb AB, Kamel OW, LeBrun DP, Warnke RA (1992) Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/cyclin monoclonal antibodies. Am J Pathol 141(6): 1453–1457

    PubMed  Google Scholar 

  12. Giri DD, Nottingham JF, Lawry J (1989) Silver binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry. J Pathol 157: 307–313

    PubMed  Google Scholar 

  13. Hall PA, Levision DA, Wods DA,et al (1990) Proliferating cell nuclear antigen (PCNA) immunohistolocalisation in paraffin sections. An index of cell proliferation with evidence of deregulated expression in some neoplasm. J Pathol 162: 285–294

    PubMed  Google Scholar 

  14. Howat AJ, Giri DD, Cotton DWK, Slater DN (1989) Nucleolar organizer regions in spitz nevi and malignant melanomas. Cancer 63: 474–478

    PubMed  Google Scholar 

  15. Hsu DW, Pardo FS, Efird JT, Linggood RM, Hedley-Whyte T (1994) Prognostic significance of proliferative indices in meningiomas. J Neuropath Exp Neurol 53: 247–255

    PubMed  Google Scholar 

  16. Jellinger K, Slowik F (1975) Histological subtypes and prognostic problems in meningiomas. J Neurol 208: 279–298

    PubMed  Google Scholar 

  17. Kleihues P, Burger PC, Scheithauer BW (1993) Histological typing of tumours of the central nervous system. World Health Organization International Histological Classification of Tumours, 2nd Ed. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  18. Korkolopoulo P, Christodoulou P, Papanikalaou A, Thomas-Tsagli E (1993) Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histologic type and tumor grade. Am J Surg Pathol 17(9): 912–919

    PubMed  Google Scholar 

  19. Louis DN, Meehan SM, Ferrante RJ, Hedley-Whyte ET (1992) Use of silver nucleolar organizer region (AgNOR) technique in differential diagnosis of central nervous system neoplasia. J Neuropathol Exp Neurol 51(2): 150–157

    PubMed  Google Scholar 

  20. Louis DN, Edgerton S, Thor AD,et al (1991) Proliferating cell nuclear antigen and Ki67 immunohistochemistry in brain tumors: a comparative study. Acta Neuropathol 81(6): 675–679

    PubMed  Google Scholar 

  21. Maier H, Morimura T, Öfner D, Hallbrucker C, Kitz K, Budka H (1990) Argyrophilic nucleolar organizer region proteins (Ag-NORs) in human brain tumors: relations with grade of malignancy and proliferation indices. Acta Neuropathol 80: 156–162

    PubMed  Google Scholar 

  22. Maier H, Öfner D, Hittmair A, Kitz K, Budka H (1992) Classic, atypical and anaplastic meningioma: three histopathological subtypes of clinical relevance J Neurosurg 77: 616–623

    PubMed  Google Scholar 

  23. Mirimanof RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL (1985) Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62: 18–24

    PubMed  Google Scholar 

  24. Morris GF, Mathews MB (1989) Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Chem 264: 13856–13864

    PubMed  Google Scholar 

  25. Murray PG, Boldy AR, Crackers J, Ayres JG (1989) Sequential demonstration of antigens and Ag-NORs in frozen and paraffin sections. J Pathol 159: 169–172

    PubMed  Google Scholar 

  26. Ogata K, Kurki P, Cells JE, Nakamura RM, Tan EM (1987) Monoclonal antibodies to a nuclear protein (PCNA/Cyclin) associated with DNA replication. Exp Cell Res 168: 475–486

    PubMed  Google Scholar 

  27. Orita T, Kajiwara K, Nishizaki T, Ikeda N, Kamiryo T, Aoki H (1990) Nucleolar organizer region in meningioma. Neurosurgery 26: 43–46

    PubMed  Google Scholar 

  28. Plate KH, Rüschoff J, Behnke J, Mennel HD (1990) Proliferative potential of human brain tumours as assessed by nucleolar organizer regions (AgNORs) and Ki67-immunoreactivity. Acta Neurochir (Wien) 104: 103–109

    Google Scholar 

  29. Plate KH, Rüschoff J, Mennel HD (1992) Application of the AgNOR technique to neurooncology. Acta Histochem [Suppl XLII]: 171–178

    Google Scholar 

  30. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet JJ (1986) Improvement in the staining and in the visualization of the nucleolar organizer region at the optical level. Histochem J 18: 5–14

    PubMed  Google Scholar 

  31. Prelich G, Tan CK, Kostura M,et al (1987) Functional identity of proliferating cell nuclear antigen and a DNA polymerasedelta auxiliary protein. Nature 326: 517–520

    PubMed  Google Scholar 

  32. Rohringer M, Sutherland GR, Louw DF, Sima AAF (1989) Incidence and clinicopathological features of meningioma. J Neurosurg 71: 665–672

    PubMed  Google Scholar 

  33. Roos G, Landberg G, Huff JP, Houghten R, Takasaki Y, Tan EM (1993) Analysis of the epitopes of proliferating cell nuclear antigen recognized by monoclonal antibodies. Lab Invest 68(2): 201–210

    Google Scholar 

  34. Rüschoff J, Plate K, Bittinger A, Thomas C (1989) Nucleolar organizer regions (NORs): basic concepts and practical application in tumor pathology. Path Res Pract 185: 878–885

    PubMed  Google Scholar 

  35. Sasaki A, Nagamura H, Kimura R,et al (1992) Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (Brdu) immuostaining for brain tumours in paraffin embedded sections. Acta Neurochir (Wien) 117: 178–181

    Google Scholar 

  36. Scarpelli M, Montironi R, Sisti S,et al (1989) Quantitative evaluation of recurrent meningiomas. Pat Res Pract 185: 746–751

    Google Scholar 

  37. Scheithauer BW (1990) Tumors of meninges: proposed modification of the World Health Organization classification. Acta Neuropathol 80: 343–354

    PubMed  Google Scholar 

  38. Smith PJ, Skilbeck N, Harrison A, Cracker J (1988) The effect of a series of fixatives on the Ag-NOR technique. J Pathol 155: 109–112

    PubMed  Google Scholar 

  39. Underwood JCE, Giri DD (1988) Nucleolar organizer regions as diagnostic discriminants for malignancy. J Pathol 155: 95–96

    PubMed  Google Scholar 

  40. Vagner-Capodana AM, Grisoli F, Gambarelli D, Sedan R, Pellet W, De Victor B (1993) Correlation between histopathological findings in 75 human meningiomas. Neurosurgery 32: 892–900

    PubMed  Google Scholar 

  41. Visakorpi T (1992) Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma. J Pathol 168: 7–13

    PubMed  Google Scholar 

  42. Waseem NH, Lane DP (1990) Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA) structural conservation and detection of a nucleolar form. J Cell Sci 96: 121–129

    PubMed  Google Scholar 

  43. Zimmer C, Gottschalk J, Navarro-Cervos J (1992) Proliferating cell nuclear antigen (PCNA) in atypical malignant meningiomas. Pat Res Pract 188: 951–958

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Ege University Medical School, Izmir, Turkey

    E. Demirtaş & F. Yilmaz

  2. Department of Neurosurgery, Ege University Medical School, Izmir, Turkey

    I. Övül & K. Öner

Authors
  1. E. Demirtaş
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Yilmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Övül
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Öner
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This study was sponsored by the Ege University Research Foundation.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Demirtaş, E., Yilmaz, F., Övül, I. et al. Recurrence of meningiomas versus proliferating cell nuclear antigen (PCNA) positivity and AgNOR counting. Acta neurochir 138, 1456–1463 (1996). https://doi.org/10.1007/BF01411126

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01411126

Keywords

Search

Navigation